Back to search
A phase I pharmacokinetic (PK) and pharmacodynamic (PD) trial of weekly 17-allylamino-17 demethoxygeldanamycin (17AAG, NSC-704057) in patients with advanced tumors
Data up to Jan 2025
Published2004
Citations4
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...